Skip to main content
. 2021 Aug 1;12(5):1168–1178. doi: 10.1002/jcsm.12754

Figure 2.

Figure 2

Associations between the status of metabolic dysfunction‐associated fatty liver disease (MAFLD)/sarcopenia and atherosclerotic cardiovascular disease (ASCVD) risk by quartile stratification. When ASCVD risk score was stratified by quartiles, the ASCVD risk significantly increased from subjects without MAFLD to non‐sarcopenic subjects with MAFLD and sarcopenic subjects with MAFLD (all P for trend <0.001).